Zymeworks (ZYME) Gains from Investment Securities (2021 - 2023)

Historic Gains from Investment Securities for Zymeworks (ZYME) over the last 3 years, with Q4 2023 value amounting to $978000.0.

  • Zymeworks' Gains from Investment Securities fell 9045.85% to $978000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.9 million, marking a year-over-year decrease of 8100.0%. This contributed to the annual value of $3.2 million for FY2024, which is 6731.58% up from last year.
  • Zymeworks' Gains from Investment Securities amounted to $978000.0 in Q4 2023, which was down 9045.85% from $423000.0 recorded in Q3 2023.
  • Zymeworks' Gains from Investment Securities' 5-year high stood at $178.7 million during Q4 2021, with a 5-year trough of -$25.3 million in Q1 2022.
  • For the 3-year period, Zymeworks' Gains from Investment Securities averaged around $27.2 million, with its median value being $978000.0 (2023).
  • Per our database at Business Quant, Zymeworks' Gains from Investment Securities crashed by 9426.49% in 2022 and then skyrocketed by 10197.4% in 2023.
  • Over the past 3 years, Zymeworks' Gains from Investment Securities (Quarter) stood at $178.7 million in 2021, then tumbled by 94.26% to $10.2 million in 2022, then plummeted by 90.46% to $978000.0 in 2023.
  • Its Gains from Investment Securities was $978000.0 in Q4 2023, compared to $423000.0 in Q3 2023 and $499000.0 in Q1 2023.